Quantitative analysis of early postoperative cerebral blood flow contributes to the prediction and diagnosis of cerebral hyperperfusion syndrome after revascularization surgery for moyamoya disease

Neurological Research

Volumn 37, Issue 2, 2015, Pages 131-138

  Fujimura, Miki ^a   Niizuma, Kuniyasu ^a   Endo, Hidenori ^b   Sato, Kenichi ^a   Inoue, Takashi ^a   Shimizu, Hiroaki ^a   Tominaga, Teiji ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOHNAN HOSPITAL   (Japan)

Author keywords

Cerebral hyperperfusion; Extracranial intracranial bypass; Moyamoya disease; Single photon emission computed tomography; Surgical Complication

Indexed keywords

SUPEROXIDE DISMUTASE; RADIOACTIVE IODINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ANXIETY; ARTICLE; BEHAVIOR; BRAIN FUNCTION; CONTROLLED STUDY; HIPPOCAMPUS; MALE; MEMORY; MOBILE PHONE; MORRIS WATER MAZE TEST; NERVE INJURY; NONHUMAN; OPEN FIELD TEST; RADIOFREQUENCY; RADIOFREQUENCY RADIATION; RAT; SPATIAL LEARNING; SWIMMING; ADOLESCENT; ADULT; ADVERSE EFFECTS; AGED; BRAIN CIRCULATION; BRAIN HEMORRHAGE; CEREBRAL REVASCULARIZATION; COMPLICATION; FEMALE; FUNCTIONAL NEUROIMAGING; HUMAN; MIDDLE AGED; MOYAMOYA DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYNDROME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CEREBRAL HEMORRHAGE; CEREBRAL REVASCULARIZATION; CEREBROVASCULAR CIRCULATION; FEMALE; FUNCTIONAL NEUROIMAGING; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; MOYAMOYA DISEASE; PERFUSION IMAGING; POSTOPERATIVE COMPLICATIONS; SYNDROME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; YOUNG ADULT;

EID: 84919326881     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132814Y.0000000432     Document Type: Article

References (25)

1. Suzuki J, Takaku A. Cerebrovascular ‘moyamoya’ disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20:288-99.
2. Guzman R, Lee M, Achrol A, Bell-Stephens T, Kelly M, Do HM, et al. Clinical outcome after 450 revascularization procedures for moyamoya disease. J Neurosurg. 2009;111:927-35.
3. Houkin K, Ishikawa T, Yoshimoto T, Abe H. Direct and indirect revascularization for moyamoya disease: surgical techniques and peri-operative complications. Clin Neurol Neurosurg. 1997;99(Suppl 2):S142-5.
4. Okada Y, Shima T, Nishida M, Yamane K, Yamada T, Yamanaka C. Effectiveness of superficial temporal arterymiddle cerebral artery anastomosis in adult moyamoya disease: cerebral hemodynamics and clinical course in ischemic and hemorrhagic varieties. Stroke. 1998;29:625-30.
5. Furuya K, Kawahara N, Morita A, Momose T, Aoki S, Kirino T. Focal hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease. Case report. J Neurosurg. 2004;100:128-32.
6. Ogasawara K, Komoribayashi N, Kobayashi M, Fukuda T, Inoue T, Yamadate K, et al. Neural damage caused by cerebral hyperperfusion after arterial bypass surgery in a patient with moyamoya disease: case report. Neurosurgery. 2005;56: E1380.
7. Fujimura M, Kaneta T, Mugikura S, Shimizu H, Tominaga T. Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease. Surg Neurol. 2007;67:273-82.
8. Kim JE, Oh CW, Kwon OK, Park SQ, Kim SE, Kim YK. Transient hyperperfusion after superficial temporal artery/middle cerebral artery bypass surgery as a possible cause of postoperative transient neurological deterioration. Cerebrovasc Dis. 2008;25:580-6.
9. Fujimura M, Mugikura S, Kaneta T, Shimizu H, Tominaga T. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. Surg Neurol. 2009;71:442-7.
10. Fujimura M, Shimizu H, Inoue T, Mugikura S, Saito A, Tominaga T, et al. Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after EC-IC bypass for moyamoya disease: Comparative study with non-moyamoya patients using 123I-IMP-SPECT. Neurosurgery. 2011;68:957-65.
11. Kawamata T, Kawashima A, Yamaguchi K, Hori T, Okada Y. Usefulness of intraoperative laser Doppler flowmetry and thermography to predict a risk of postoperative hyperperfusion after superficial temporal artery-middle cerebral artery bypass for moyamoya disease. Neurosurg Rev. 2011;34:355-62.
12. Uchino H, Kuroda S, Hirata K, Shiga T, Houkin K, Tamaki N. Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT/positron emission tomography study. Stroke. 2012;43:2610-6.
13. Kaku Y, Iihara K, Nakajima N, Kataoka H, Fukuda K, Masuoka J, et al. Cerebral blood flow and metabolism of hyperperfusion after cerebral revascularization in patients with moyamoya disease. J Cereb Blood FlowMetab. 2012;32:2066-75.
14. Sundt TM Jr, Sharbrough FW, Piepgras DG, Kearns TP, Messick JM Jr, O’Fallon WM. Correlation of cerebral blood flow and electroencephalographic changes during carotid endarterectomy: with results of surgery and hemodynamics of cerebral ischemia. Mayo Clin Proc. 1981;56:533-43.
15. Solomon RA, Loftus CM, Quest DO, Correll JW. Incidence and etiology of intracerebral hemorrhage following carotid endarterectomy. J Neurosurg. 1986;64:29-34.
16. Piepgras DG, Morgan MK, Sundt TM Jr, Yanagihara T, Mussman LM. Intracerebral hemorrhage after carotid endarterectomy. J Neurosurg. 1988;68:532-6.
17. Fujimura M, Shimizu H, Mugikura S, Tominaga T. Delayed intracerebral hemorrhage after superficial temporal arterymiddle cerebral artery anastomosis in a patient with moyamoya disease: possible involvement of cerebral hyperperfusion and increased vascular permeability. Surg Neurol. 2009;71:223-7.
18. Fujimura M, Inoue T, Shimizu H, Saito A, Mugikura S, Tominaga T. Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease. Cerebrovasc Dis. 2012;33:436-45.
19. Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis; Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo). 2012;52:245-66.
20. Iida H, Itoh H, Nakazawa M, Hatazawa J, Nishimura H, Onishi Y, et al. Quantitative mapping of regional cerebral blood flow using iodine-123-IMP and SPECT. J Nucl Med. 1994;35:2019-30.
21. Ogasawara K, Ito H, Sasoh M, Okuguchi T, Kobayashi M, Yukawa H, et al. Quantitative measurement of regional cerebrovascular reactivity to acetazolamide using iodine-123-IMP autoradiography with SPECT: validation study using oxygen-15-water with PET. J Nucl Med. 2003;44:520-5.
22. Morisawa H, Kawamata T, Kawashima A, Hayashi M, Yamaguchi K, Yoneyama T, et al. Hemodynamics and changes after STA-MCA anastomosis in moyamoya disease and atherosclerotic cerebrovascular disease measured by micro-Doppler ultrasonography. Neurosurg Rev. 2013;36:411-9.
23. Fujimura M, Niizuma K, Inoue T, Sato K, Endo H, Shimizu H, et al. Minocycline prevents focal neurologic deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease. Neurosurgery. 2014;74:163-70.
24. Nakagawa A, Fujimura M, Arafune T, Sakuma I, Tominaga T. Clinical implications of intraoperative infrared brain surface monitoring during superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. J Neurosurg. 2009;111:1158-64.
25. Hayashi T, Shirane R, Fujimura M, Tominaga T. Postoperative neurological deterioration in the pediatric moyamoya disease: watershed shift and hyperperfusion. J Neurosurg Pediatr. 2010;6:74-82.